Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Disodiumpyrophosphate (Na2H2PPi) Absorption in Pseudoxanthoma Elasticum (PXE)

NCT04441671 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.

NCT NCT04441671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04441671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Disodiumpyrophosphate (Na2H2PPi) Absorption in Pseudoxanthoma Elasticum (PXE)
Lead sponsor
Tampere University Hospital
Phase
Phase 2
Overall status
Withdrawn
Start date
December 8, 2020
Completion date
April 1, 2021
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pseudoxanthoma elasticum